OPALE, the Organization
for Partnerships in Leukemia
The OPALE Carnot institute is a healthcare industry’s preferred partner for the research and development of innovative solutions aimed at diagnosis, treatment and follow-up of patients in the field of leukemia and related diseases, the deadliest blood cancer and first child cancer.
Unique leukemia R&D partnering opportunities
The OPALE Carnot Institute gives healthcare companies unique access to the expertise of an internationally unparalleled consortium in the field of leukemia and related diseases. Our aim is to prolong or save the lives of more patients by accelerating therapeutic and diagnostic innovation across the entire research and development value chain.
Explore our offer
Carnot, a label of excellence
Granted by the French Ministry of Higher Education, Research and Innovation, the Carnot label is prestigious and highly selective.
Being labelled Carnot is a guarantee of scientific and operational excellence in R&D collaborations for our industrial partners.
The Carnot institutes follow their namesake Charter to guarantee top-tier collaborative research, effectively driving industrial advancements while ensuring ongoing scientific revitalization within the Carnot community.
"The OPALE Carnot Institute addresses many of the needs of manufacturers in the leukemia market, thanks to the specialization and depth of its R&D offering, accessible through a one-stop shop."
Medical Director of a pharmaceutical company
Member of OPALE's Strategic Advisory Committee
"Accelerating the emergence of innovative solutions for the diagnosis, treatment, and follow-up of patients in the field of leukemia and related diseases"
Pr Hervé Dombret
OPALE's Chairman
News
One Health : l’Institut Carnot OPALE au rendez-vous de la recherche partenariale avec l’ANRT
05/03/2026
Le 18 mars 2026, l’Institut Carnot OPALE participera au colloque ANRT consacré à la recherche partenariale au service de l’approche One Health à PariSanté Campus.
> Read moreL’Institut Carnot OPALE présent au PSCC Innovation Forum 2026 pour renforcer les collaborations en oncologie
17/02/2026
Le 4 février 2026, l’Institut Carnot OPALE a participé au PSCC Innovation Forum pour renforcer ses collaborations en oncologie et en recherche sur les leucémies.
> Read moreJournée mondiale contre le cancer : à l’Institut Carnot OPALE, la recherche partenariale accélère l’innovation contre les leucémies
04/02/2026
À l’occasion de la Journée mondiale contre le cancer, l’Institut Carnot OPALE met en avant sa recherche partenariale sur les leucémies, en lien avec les hôpitaux, les industriels et son partenaire associatif Laurette Fugain.
> Read more